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In comparison to Alzheimer’s dementia, individuals with
dementia with Lewy bodies are disproportionately affected by
visuoperceptual impairments and up to 80% experience recurrent
complex visual hallucinations.1 These clinical and neuro-
psychological features strongly suggest that the visual system in
dementia with Lewy bodies is dysfunctional, although precisely
which components are affected and how remains to be clarified.
Single photon emission computerised tomography (SPECT) and
fluorodeoxyglucose positron emission tomography (PET) studies
in dementia with Lewy bodies have demonstrated occipital
and occipito-parietal visual association area hypoperfusion and
hypometabolism respectively.2–5 However, occipital deficits are
not consistently reported in dementia with Lewy bodies.3
Functional magnetic resonance imaging (fMRI) has been used
to examine cortical visual function, although there has been only
one study to date in patients with dementia with Lewy bodies,
which examined cortical activation and deactivation patterns
compared with patients with Alzheimer’s disease using a number
of visual tasks.6 However, we are not aware of studies investigating
deficits in lower visual processing in dementia with Lewy bodies.
There is a larger literature looking at cortical visual function in
Parkinson’s disease,7–9 although cortical visual activation patterns
vary considerably depending on the study paradigm. Overall, there
remains a need to understand the functional integrity of the
cortical visual system in dementia with Lewy bodies. We sought
to address this issue using the application of fMRI and arterial
spin labelling (ASL)-MRI to dementia with Lewy bodies. Our
specific hypotheses were:
1 that individuals with dementia would show evidence of
deficits in higher visual areas on blood oxygen-level dependent
(BOLD) response to visual stimuli compared with controls,
but lower visual areas would show normal function;
2 that using ASL-MRI we would find posterior brain hypo-
perfusion at rest in individuals with dementia compared
with controls; however, in light of increasing evidence for
intact lower visual areas in dementia with Lewy bodies, we
expected perfusion deficits to be less marked here than in
higher areas.
Method
Participants
Participants with dementia with Lewy bodies (DLB group) were
recruited from a local community-dwelling population of
individuals who had been referred to geographically based old
age psychiatry and neurology services. The control group was
selected from friends and spouses of participants included in this
and previous studies. The study was approved by the local ethics
committee.
Diagnosis of probable dementia with Lewy bodies was made
independently by two experienced senior clinicians using the
revised International Consensus Guidelines for dementia with
Lewy bodies.10 Cognitive function was tested using the Cambridge
Cognitive Examination11 (CAMCOG, maximum score 105) and
the Mini-Mental State Examination12 (MMSE, maximum score
30). The presence and severity of any extrapyramidal signs were
graded using the motor component of the Unified Parkinson’s
Disease Rating Scale (UPDRS).13
Control participants included in the study demonstrated no
evidence of dementia (from history and score 480 on CAM-
COG). Exclusion criteria for all participants included contra-
indications for MRI, severe visual impairment, previous history
of alcohol or substance misuse, significant neurological or
psychiatric history, focal brain lesions on brain imaging or the
presence of other severe or unstable medical illness.
All participants had measurement of their best near visual
acuity on Landolt broken rings or Snellen chart (test distance
40 cm) after correction of any refractive errors. Assessment of
visuoperceptual function was carried out using previously
described angle discrimination and overlapping figures tasks, with
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Background
Visual hallucinations and visuoperceptual deficits are
common in dementia with Lewy bodies, suggesting that
cortical visual function may be abnormal.
Aims
To investigate: (1) cortical visual function using functional
magnetic resonance imaging (fMRI); and (2) the nature and
severity of perfusion deficits in visual areas using arterial spin
labelling (ASL)-MRI.
Method
In total, 17 participants with dementia with Lewy bodies (DLB
group) and 19 similarly aged controls were presented with
simple visual stimuli (checkerboard, moving dots, and
objects) during fMRI and subsequently underwent ASL-MRI
(DLB group n=15, control group n=19).
Results
Functional activations were evident in visual areas in both
the DLB and control groups in response to checkerboard and
objects stimuli but reduced visual area V5/MT (middle
temporal) activation occurred in the DLB group in response
to motion stimuli. Posterior cortical perfusion deficits
occurred in the DLB group, particularly in higher visual
areas.
Conclusions
Higher visual areas, particularly occipito-parietal, appear
abnormal in dementia with Lewy bodies, while there is a
preservation of function in lower visual areas (V1 and
V2/3).
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20 trials administered for each task.14 Prior to MRI in the DLB
group, cognitive fluctuations were assessed using the Clinician
Assessment of Fluctuation (CAF) scale and the One Day
Fluctuation Assessment Scale (ODFAS).15 For assessment of
visual hallucinations, caregivers were asked to complete the
hallucinations subscale of the Neuropsychiatric Inventory
(NPIhall), which enquires about the occurrence of visual
hallucinations in the past month. The NPIhall score (frequency6
severity) was used in analyses to determine the association of the
severity and frequency of visual hallucinations with imaging
indices.
Neuroimaging data acquisition
Participants were scanned on a 3T whole body MRI scanner
(Achieva scanner; Philips Medical System, The Netherlands).
Images acquired included a standard whole brain structural scan
(three-dimensional (3D) MPRAGE, sagittal acquisition, slice
thickness 1.2mm, in plane resolution 0.9460.94mm; repetition
time (TR) 9.6ms; echo time (TE) 4.6ms; flip angle 88; SENSE
factor 2). Functional MRI data were collected with a gradient-echo
echo planar imaging (EPI) sequence (TR= 1.92 s; TE = 40ms; field
of view (FOV) 1926192mm2; matrix size 64664, flip angle 908,
27 slices, slice thickness 3mm, slice gap 1mm). The length of
each functional run varied between the different stimulus
conditions (see below): 100 volumes (192 s) were acquired for
the checkerboard stimuli; 183 volumes (351 s) were acquired for
the moving dot stimuli; and 234 volumes (449 s) were acquired
for objects stimuli.
Subsequently, within the same scanning session, resting
cerebral perfusion imaging data were collected with the
participants instructed to close their eyes during the acquisition.
Cerebral perfusion imaging used a multislice pulsed ASL sequence
– FAIR (Flow sensitive Alternating Inversion Recovery16) – with
4 slices (TE = 26ms, TR= 4000ms, inflow time 1700ms, in plane
resolution 464mm2, slice thickness 6mm, FOV=2566256mm2)
and incorporated a 10ms bipolar gradient to suppress bulk flow.
Two spatially contiguous acquisitions of FAIR giving 8 slices were
acquired, angled at 308 to the corpus callosum to cover the
occipital and inferior parietal lobe.
To quantify T1 for use in the perfusion quantification, we used
a rapid inversion recovery gradient-echo EPI sequence with:
TR= 15000ms; TE= 24ms; T1 from 0.25 s to 2.5 s in 12 equal
steps; FOV= 2566208mm; SENSE factor 2; in plane resolution
262mm; 72 slices, slice thickness 2mm.
Functional MRI stimulus presentation
Previously reported activation differences on BOLD fMRI between
controls and the DLB group may be due in part to task
performance differences.6 To limit the confounding effect of
performance (either over- or underactivity) so that we could
specifically test for (any) differences in visual cortical processing,
our participants passively viewed simple visual stimuli rather than
carrying out an active behavioural task. Visual stimuli were back-
projected onto a screen at the foot of the scanner and individuals
viewed the stimuli via a mirror positioned above their eyes.
Functional MRI compatible goggles with lenses that ranged from
74.0 to 4.0 diopters (0.5 increment) were used to correct any
refractive errors.
Participants were asked to focus on a central cross-hair set
against a grey background. The stimulus presentation was
controlled by the psychophysics toolbox (http://psychtoolbox.
org/; extension for Matlab (Mathworks, Natick, Massachusetts,
USA).17
A block design was used for three different stimulus
conditions: flashing checkerboards (checkerboard stimulus),
pictures of objects (objects stimulus), and moving dot fields
(motion stimulus). The checkerboard stimulus consisted of five
19.2 s blocks of a flashing black-and-white checkerboard,
alternating with five 19.2 s baseline blocks of a blank screen. The
checkerboard flickered with a frequency of 7.5Hz. The object
stimulus consisted of seven 18 s blocks of intact pictures of objects,
alternating with seven 18 s blocks of images of ‘scrambled’ texture
patterns, which had the same low-level contrast and luminance as
the pictures of the objects. Between blocks, a grey screen with
fixation cross was displayed. Six stimuli were presented on each
block. The stimuli were shown for 1 s, with a 2 s fixation cross
between stimuli. For the motion stimulus, there were 18 9.6 s
blocks of expanding white dots, alternating with 18 9.6 s blocks
of stationary but flickering white dots. All stimuli subtended a
maximum of 48 of visual angle. The checkerboard stimulus was
used to stimulate lower visual areas (V1–V3), the objects stimulus
was used to stimulate higher visual areas in lateral-occipital
cortex,18–20 and the motion stimulus was used to stimulate
posterior temporal areas.21
Although participants passively viewed the visual stimuli to
avoid performance confounds, to maintain their attention to the
stimuli during the fMRI component of the study, a small inter-
mittent pink dot appeared approximately every 30 s over the
central fixation point to which participants were instructed
to respond to by squeezing a response button placed in their
right hand, with disappearance of the dot either on response or
after 5 s.
Functional MRI analysis
For each participant, the T1 anatomical image was segmented and
spatially normalised in SPM5 (www.fil.ion.ucl.ac.uk/spm/) using
the default parameters. The fMRI data for each stimulus condition
were first motion corrected by aligning all functional images to the
first image, and then coregistered with the T1 anatomical image.
The spatial normalisation parameters from the T1 segmentation
were used to write out the EPI data in standard space with a voxel
size of 36363mm. The normalised images were then smoothed
(66666mm full width half-maximum Gaussian kernel). A high
pass filter of 128 s was used, and serial correlations were removed
with SPM’s AR(1) model.
The general linear model (GLM) in SPM was used to conduct
a whole brain analysis of the fMRI data. For each stimulus
condition, we created a design matrix by convolving the time
course of the two block types (i.e. flashing checkerboard and
blank; objects and scrambled images; and moving dots and static
flashing dots), with the canonical haemodynamic response
function (HRF) and its first derivative. The six parameters from
the motion correction for each functional run were included in
the design matrix as covariates of no interest. The regressors were
fitted to the fMRI data to produce beta estimates for each
regressor. Individual participant and second-level (random
effects) group analyses were conducted making comparisons
between groups. Contrast images were generated from beta
estimates for the following comparisons: checkerboard v. baseline
(checkerboard stimulus contrast), moving dots v. static dots
(motion stimulus contrast), and objects v. scrambled images
(objects stimulus contrast). Results are shown thresholded at
P50.05 family wise error corrected for multiple comparisons at
the voxel level and we report clusters only 520 voxels in size.
We used the SPM anatomy toolbox (www2.fz-juelich.de/inm/
inm-1/spm_anatomy_toolbox) to determine the location of each
cluster.
492
Taylor et al
Visual cortex in dementia with Lewy bodies
To maximise sensitivity, we also performed a region of interest
(ROI) analysis focusing on the visual areas. For fMRI data, five
ROIs in Montreal Neurological Institute (MNI) space were
defined averaging across left and right hemispheres. Four ROIs
(V5/MT (middle temporal area); V1; V2 and V3 combined; and
V4) were taken from the SPM anatomy toolbox. A fifth area
(lateral occipital cortex, LOC) was a 1 cm diameter sphere
(20 voxels in volume) centred on the average of coordinates
described in a number of previously published reports (online
Fig. DS1).18–20 For each participant, the magnitude of activation
for the different conditions in each ROI was determined by
averaging the relevant beta parameter from each participant’s
fitted beta estimates from the general linear model.
Cerebral perfusion analysis
T1 was determined by fitting the inversion recovery images with a
relaxation curve on a pixel by pixel basis. Motion correction was
applied to each ASL image-set. The ASL images and the T1 map
were co-registered with the 3D-T1 anatomical scan. Each ASL scan
was split into ‘control’ and ‘tag’ image series. Each series was then
averaged and the difference image dM was created by subtracting
the mean control image from the mean tag images, while the
magnitude image M was calculated by taking the average of all
ASL images. Perfusion values were then calculated on a voxel-wise
basis from the dM, M and T1 images, using a value of 1.932 s
for T1 of blood, and 0.9ml/g for the blood–brain partition
coefficient.22
The calculated perfusion images were then spatially
normalised, using the parameters from the 3D-T1 scan. Since
we had limited spatial coverage, a mask in MNI space was created
of voxels which had ASL data from all participants. As well as
using the ROIs from fMRI analysis (V1, V2/3, V4, V5/MT and
LOC), we derived a further two from the Harvard Oxford atlas
(in FSL, www.fmrib.ox.ac.uk/fsl) encompassing the precuneus
and the superior lateral occipital (SLO) region because of the
previously reported widespread posterior perfusion found in
dementia with Lewy bodies in these areas.23,24 We calculated mean
perfusion within these ROIs in MNI space.
Statistics
The NPIhall score in the DLB group was correlated against fMRI
beta values and ASL perfusion rates in the ROIs. Comparison of
fMRI and perfusion data was also made using ROIs between the
control and DLB groups correcting for age, even though groups
were not significantly different, as this has been suggested to be
a significant factor leading to region-specific decreases and
increases in perfusion.25 Group comparisons were made using
Student t-test and we hypothesed that there would be no differ-
ence in ROI BOLD activations between the DLB and control
groups in V1–4 to checkerboard stimulus, but reduced activations
in V5/MT and LOC to motion and object visual stimuli respec-
tively. For the ASL-MRI data, we hypothesed that ROI perfusion
would be normal in V1–3 but reduced in higher visual areas. Sec-
ondary analyses were done to ensure that any notable findings
were related to group differences in visual function rather than
owing to other factors by examining the association between key
demographic/disease factors (age, visual acuity, UPDRS motor
subscale score, CAMCOG score, age at onset of dementia,
duration of any dementia, CAF and medication use) and imaging
ROI. Parametric and non-parametric correlations were used
depending on the normality of the data. All values reported are
means (s.e.) unless otherwise stated and t-tests were two-tailed.
Results
Demographics
We recruited 19 individuals with dementia with Lewy bodies and
19 controls; one patient with dementia was subsequently excluded
on the basis that he could not tolerate lying flat in the MRI
scanner. Another person with dementia failed to respond to the
motor task during scanning and demonstrated no occipital lobe
activation to the checkerboard stimulus and thus their data were
not included in the fMRI analysis. Arterial spin labelling MRI data
from two other participants with dementia were excluded from
the perfusion analysis due to excessive movement artefact during
ASL-MRI acquisition, although fMRI data from these individuals
were available. Thus, data were available on 17 individuals with
dementia for the fMRI analyses and 15 individuals with dementia
for the ASL-MRI analyses.
Demographic features of the participants who completed the
study are shown in Table 1. Age, gender and visual acuity were
comparable between control and DLB groups with, as expected,
reduced cognitive performance on CAMCOG and MMSE, lower
visuoperceptual task scores and higher UPDRS scores in the
DLB group compared with controls.
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Table 1 Demographic, cognitive and motor characteristics
of participants included in studya
Control group
(n=19)
DLB group
(n=17) P
Age, years: mean (s.d.) 77.6 (7.1) 81.2 (5.6) 0.10
Males: females, n 11:8 10:8 1.00
UPDRS motor subscale,
mean (s.d.) 0.9 (1.6) 33.9 (14.0) <0.001
MMSE, mean (s.d.) 29.0 (1.2) 18.8 (5.1) <0.001
CAMCOG, mean (s.d.)
Total score
Executive subscore
Memory subscore
96.5 (3.4)
22.1 (3.4)
23.6 (2.1)
64.8 (14.0)
10.4 (4.8)
15.6 (4.2)
<0.001
<0.001
<0.001
Visual acuity (decimalised),
mean (s.d.) 0.64 (0.29) 0.55 (0.26) 0.32
Age at onset of dementia,
mean (s.d.) – 77.4 (5.7) N/A
Duration of dementia,
months: mean (s.d.) – 45.4 (32.2) N/A
CAF, mean (s.d.) – 8.2 (4.4) N/A
ODFAS, mean (s.d.) – 6.2 (4.7) N/A
NPIhall, mean (s.d.) – 3.1 (2.3) N/A
Angle discrimination task
(score out of 20), mean (s.d.) 19.9 (0.2) 15.5 (5.6) <0.001
Overlapping figures task
(score out of 20), mean (s.d.)
19.8 (0.3) 14.8 (3.6) <0.001
On cholinesterase inhibitor,
n (%) – 13 (72) N/A
On anti-Parkinson
medication, n (%) – 5 (28) N/A
L-dopa dose equivalent,
mg:b mean (s.d.) – 234.4 (186.6) N/A
DLB, dementia with Lewy bodies; UPDRS, Unified Parkinson’s Disease Rating Scale;
MMSE, Mini-Mental State Examination; CAMCOG, Cambridge Cognitive Examination;
CAF, Clinician Assessment of Fluctuation; ODFAS, One Day Fluctuation Assessment
Scale; NPIhall, Neuropsychiatric Inventory hallucinations subscale score (frequency6
severity of hallucinations).
a. For comparison of data in control group v. DLB group, independent t-tests
were used for continuous data and Pearson chi-squared for categorical data.
b. Calculated equivalent L-dopa dose for those in the DLB group on dopaminergic
medication.
Results in bold are significant.
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Functional MRI activations
Distinct and overlapping networks (P50.05 family wise error
corrected) were evident for each of the visual stimuli for both
control and DLB groups (Fig. 1 and Tables 2–4 and online Fig.
DS2). Significant cluster activations for checkerboard stimulus
lay within V1 and V2 for both control and DLB groups, with
controls in addition showing significant clusters over V3. For
the motion stimulus contrast, both DLB and control groups had
significant activations in V3 and V4, with activation in V5/MT
only present in the control group. The objects stimulus contrast
demonstrated activation clusters in controls overlying the left
inferior temporal gyrus, left fusiform gyrus, left inferior and
middle occipital gyrus. No clusters 520 voxels were noted in
participants with dementia with this stimulus.
Whole brain analyses comparing groups, however, did not
demonstrate any significant differences in activation between
DLB and control groups for each of the tasks. Region of interest
analysis (Fig. 2) for lower visual areas confirmed this finding, with
no differences in activity between the control and DLB groups for
checkerboard stimulus (V1 ROI) or objects stimulus analyses
(LOC ROI). However, the ROI localised on the V5/MT showed
that the DLB group had reduced activation to the motion stimulus
in this area compared with controls (P=0.02). The results of the
exploratory analyses of BOLD activity in the other ROIs for each
of the tasks are shown in online Table DS1. Of note, there were no
significant differences between DLB and control groups in the
BOLD response to the three visual stimuli in V1, V2/3 or V4.
Cerebral perfusion
Cerebral perfusion within the segment of brain covered by the
FAIR image acquisition was significantly reduced in the DLB
group compared with controls within inferior parietal and
posterior cingulate/precuneus (Fig. 3 and Table 5 and online
Fig. DS3). Lower visual areas (V1–3) appeared relatively intact.
Perfusion deficits in dementia compared with controls were
confirmed in ROI analysis (Fig. 4). Correcting for age, the
reduction was not significant in V1 (P=0.25) or V2/3 (P=0.19),
but approached significance in V4 (P=0.08). The reduction was
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Checkerboard
Motion
Objects
Control group DLB group
Fig. 1 Group activation maps for checkerboard, motion and
objects stimuli. Blue areas indicate significant BOLD activation.
See online Fig. DS2 for graduated colour activation maps.
Thresholded at P50.05 family wise error corrected and superimposed on average
brain template. Contrasts include checkerboard v. static image (checkerboard
stimulus), moving dots v. static image (motion stimulus) and objects v. scrambled
image (objects stimulus). BOLD, blood oxygen-level dependent; DLB, dementia with
Lewy bodies.
Table 2 Checkerboard stimuli: anatomical locations of BOLD activations in participants to visual stimulia
Cluster P corrected Size (voxels) Anatomical loci Maximum Z Maximum Z position (MNI)
Control group 50.001 899 Right V1
Right area V2
Left V3
Left V2
6.80 9, 793, 79
DLB group 50.001 541 Right V1
Right V2
Left V2
Left V1
6.82 18, 793, 0
BOLD, blood oxygen-level dependent; MNI, Montreal Neurological Institute.
a. Significant clusters in Statistical Parametric Mapping analysis, local maxima more than 4mm apart. Data presented were all significant at the P50.05 family wise error corrected level.
Table 3 Motion stimuli: anatomical locations of BOLD activations in participants to visual stimulia
Cluster P corrected Size (voxels) Anatomical loci Maximum Z Maximum Z position (MNI)
Control group
1 50.001 27 Left V4
Left V3
5.73 721, 784, 718
2 50.001 21 Right V2
Right V3
5.44 18, 784, 715
4 50.001 27 Left V5 5.39 742, 769, 3
5 50.001 34 Right V5 5.24 45, 766, 0
BOLD, blood oxygen-level dependent; MNI, Montreal Neurological Institute.
a. Significant clusters in Statistical Parametric Mapping analysis, local maxima more than 4mm apart. Data presented were all significant at the P50.05 family wise error corrected level.
Visual cortex in dementia with Lewy bodies
significant in: V5/MT, P= 0.05; LOC, P=0.05; precuneus,
P50.001; SLO, P= 0.004.
Associations between clinical variables and imaging
changes in participants with dementia
There were no significant correlations between visual hallucinations
(NPIhall) score and BOLD activations, although there was a negative
relationship between V4 perfusion and NPIhall (rho =70.52,
P= 0.04; online Fig. DS4), but not perfusion in other ROIs.
Angle discrimination task scores in dementia did not correlate
significantly with either BOLD activations or perfusion. Over-
lapping figures task scores in dementia were, however, associated
with increased perfusion in lower but not higher visual areas
(V1, rho = 0.49, P=0.05; V2/3, rho = 0.55, P= 0.03; V4,
rho = 0.55, P= 0.03; online Fig. DS5).
There was no relationship between CAMCOG score, or visual
acuity and BOLD response or perfusion in any ROI in either the
control or DLB group. In the control group, participants’
perfusion in ROI of SLO and LOC correlated negatively with
age (SLO r =70.45, P=0.05; LOC r =70.58, P= 0.01), although
no relationship was noted in the DLB group. We found a negative
relationship between UPDRS score and SLO ROI perfusion (rho =
70.66, P=0.006) in participants with dementia, although there
was no association between UPDRS scores and other ROIs for
perfusion or functional BOLD activations. There were no
significant differences in BOLD or perfusion data in participants
with dementia taking or not taking cholinesterase inhibitors and
on or off dopaminergic medications.
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Table 4 Object stimuli: anatomical locations of BOLD activations in participants to visual stimulia
Cluster P corrected Size (voxels) Anatomical loci Maximum Z Maximum Z position (MNI)
Control group
1 50.001 81 Left inferior temporal gyrus 6.58 742, 760, 79
Left fusiform gyrus 5.69 736, 748, 721
Left inferior occipital gyrus 6.49 739, 763, 76
2 50.001 24 Left middle occipital gyrus 5.40 736, 778, 0
BOLD, blood oxygen-level dependent; MNI, Montreal Neurological Institute.
a. Significant clusters in Statistical Parametric Mapping analysis, local maxima more than 4mm apart. Data presented were all significant at the P50.05 family wise error corrected level.
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Fig. 2 Bar chart showing region of interest (ROI) analysis
comparing control group v. dementia with Lewy bodies (DLB)
group with regard to functional BOLD activations to different
visual stimuli (mean (s.e.)).
c_V1, checkerboard activation in V1 ROI; c_V2/3, checkerboard activation in V2/3 ROI;
c_V4, checkerboard activation in V4 ROI; m_V5/MT, motion activation in ROI V5/MT;
o_LOC, objects activation in ROI lateral occipital complex; BOLD, blood oxygen-level
dependent. There were no significant differences between groups for ROI activations
except for motion stimulus contrast (P=0.02). *P50.05.
Table 5 Anatomical locations of perfusion deficits in DLB group v. aged control group
Cluster P corrected Size (voxels) Anatomical loci Maximum Z Maximum Z position (MNI)
1 50.001 39 Right V1
Right V2
Right precuneus
5.22 18, –54, 12
2 50.001 20 Left inferior parietal cortex
Left supramarginal gyrus
5.11 –45, –54, 21
DLB, dementia with Lewy bodies; MNI, Montreal Neurological Institute.
Fig. 3 Statistical Parametric Mapping t-plot showing differences
in cerebral perfusion thresholded at P50.001 uncorrected at
group level between control and DLB groups (blue areas
indicating reduced perfusion in the DLB group relative to
controls) and superimposed on average brain template. Lines
demarcate boundaries of overlap of perfusion slices sampled.
See online Fig. DS3 for exemplar raw cerebral perfusion and
graduated colour SPM perfusion maps.
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Discussion
Functional activations to passively viewed
visual stimuli
We found no significant differences in fMRI response between the
control and DLB groups to checkerboard, objects or motion
stimuli in V1 and V2/V3. These findings are comparable to the
one other fMRI study in dementia with Lewy bodies by Sauer et
al.6 Although these researchers did not specifically examine striate
visual cortical activation to their visual stimuli, it was notable that
their colour task led to similar V4 activity between participants
with dementia and controls. Thus overall, given that BOLD
activity is presumed to correlate with neuronal activity,26 the
similar levels of activation to simple visual stimuli in the control
and DLB groups imply that, in lower visual areas at least, visual
processing function in dementia with Lewy bodies is not grossly
perturbed. This conclusion is reinforced by the lack of specific
pathological change evident in the occipital lobe of individuals
with dementia with Lewy bodies at the macrostructural27–29 and
microstructural level,30 comparable levels of visual cortical
excitability in dementia compared with controls31 as well as our
ASL findings (see below) of a non-significant reduction in lower
visual area perfusion.
We found reduced activation in the lateral occipito-temporal
cortex (V5/MT) on ROI analysis to the motion stimulus, which
is consistent with previous evidence that individuals with
Parkinson’s disease or dementia with Lewy bodies who
hallucinate show visual motion deficits both on behavioural
testing14 and on functional imaging.6,7 However, it is notable that
no significant differences were noted on the motion task on whole
brain analyses. Such analyses may be unduly conservative when
testing a priori hypotheses but, nonetheless, our findings should
be considered preliminary and require replication.
The potential finding of reduced activity in V5/MT to motion
stimuli, together with lack of group difference in LOC response to
objects stimuli are somewhat at odds with neuropathological
findings, although there have been very few investigations of visual
pathway pathology in dementia with Lewy bodies;30,32 Lewy body
pathology in the inferior temporal lobe has been linked to visual
hallucinations. In contrast, Lewy body deposition in occipital and
parietal areas is low. Nevertheless, perfusion (see below and
Colloby et al23 and Fong et al24) and metabolism deficits5 have
been observed in both occipito-parietal and occipito-temporal areas.
It may be the interaction between dysfunctional occipito-
temporal and occipito-parietal processing streams or indeed
disruption to visual white matter connectivity33 that contributes
to the visuoperception difficulties and visual hallucinations seen
in dementia with Lewy bodies.
Perfusion deficits in dementia with Lewy bodies
The finding of reduced posterior perfusion using ASL-MRI is
consistent with prior evidence of hypoperfusion/hypometabolism
in dementia with Lewy bodies. However, the extent to which the
occipital lobe is affected remains controversial, with Kemp et al3
showing a lack of involvement, and others occipital reductions.2,34
In part, this disparity may be driven by differences in severity and
stage of illness of the dementia cohorts involved in the different
studies.24
Dopaminergic changes may also be relevant, as we found a
negative correlation between the severity of Parkinsonism as
measured on the UPDRS and perfusion in SLO ROI. A study with
PET in patients with Parkinson’s disease35 noted a relationship
between occipital hypometabolism and nigrostriatial dysfunction,
although more recent findings using 123I-FP-CIT/SPECT and
ECD/SPECT in Parkinson’s disease with dementia and patients
with dementia with Lewy bodies36 failed to find any link between
regional cerebral perfusion and nigrostriatal loss. This combined
with a lack of any observed effect of dopaminergic medication
on perfusion in the present study indicate that the role of
dopaminergic mediated processes on visual function in dementia
with Lewy bodies is more complex and may depend on other
factors, for example, the severity of co-associated cortical neuro-
degeneration and/or concurrent changes in other neurotransmitter
systems.37
Imaging findings related to visual hallucinations,
visuoperceptual function and cholinesterase
inhibitors
There are no comparative fMRI studies in people with dementia
with Lewy bodies examining the relationship between BOLD
response and severity of hallucinations. There is a more extensive
literature in Parkinson’s disease, where studies have demonstrated
widely distributed changes in activation patterns (ranging from
the lower visual system, through to visual association areas and
frontal areas) in people who hallucinate compared with those
who do not, but there is no established or consistent pattern to
these (see e.g. Stebbins et al,7 Ramı´rez-Ruiz et al 8 and Meppelink
et al 9).
In our study we found no evidence of any association between
the severity and frequency of visual hallucinations and BOLD
activations to any of our visual task probes. The disparity of this
finding compared with the Parkinson’s disease data may be as a
result of intrinsic differences between our study and those in
people with Parkinson’s disease in terms of disease process
(dementia with Lewy bodies v. Parkinson’s diease), cognitive
function (dementia v. Parkinson’s disease without dementia),
dopaminergic/nigrostriatal deficiency, and lack of a significant
non-hallucinator group in our study.
However, we did note an association between the severity of
visual hallucinations and the degree of hypoperfusion deficits in
V4. Visual area V4 is important for colour38 and is an inter-
mediate module within the ventral visual stream for object and
form processing39 and thus hypoperfusion of this region in
association with visual hallucinations severity is certainly
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plausible. However, we did not see any association between hypo-
perfusion in higher visual areas such as the inferior temporal
cortex, and Lewy body pathology in this area has been associated
with visual hallucination occurrence.32 Nevertheless, this and
other studies in dementia with Lewy bodies and Parkinson’s
disease which have demonstrated coupling between visual
hallucinations and posterior perfusion deficits have focused
on comparing people who hallucinate with people who do
not,7–9,40 whereas in the present sample all participants with
dementia with Lewy bodies hallucinated to varying degrees. Thus,
perfusion deficits may be a marker of a neural environment that is
permissive to the manifestation of visual hallucinations, but this
does not indicate they are causally related.
Angle discrimination task and overlapping figures task are
differentially impaired in dementia with Lewy bodies compared
with other visuoperceptive tasks.14Although the neurobiological
basis of both tasks remains unclear, it is likely that the angle task
is more dependent on the occipito-parietal or dorsal visual
stream,41 and that the overlapping figures task may involve
activity within the occipito-temporal ventral stream,42 given that
this latter task requires object recognition. In the present study
we did not see any association between the angle or overlapping
figures task with BOLD activation to visual stimuli. This may
suggest that the neural substrate that is responsive to the visual
stimuli does not overlap the same structures responsible for the
performance in the visuoperceptive tasks chosen in this study.
However, there was an association between greater perfusion in
lower visual areas (V1–4) in dementia with Lewy bodies and
overlapping figures task scores, which may indicate that the
integrity of lower visual areas is important in dementia with Lewy
bodies for the maintenance of visuoperceptual function associated
with the ventral visual stream.
There were no differences in either BOLD task-related
activations or perfusion in the DLB group on or off cholinesterase
inhibitors. Previous reports have demonstrated increased occipital
perfusion in individuals treated with donepezil, a cholinesterase
inhibitor.24,43 The present study was cross-sectional and thus we
cannot exclude the possibility that cholinesterase inhibitor use
in individuals may have modulated the imaging findings.
Clinical implications
Our results suggest that lower visual areas are functionally
relatively intact and respond normally to simple visual stimuli.
Abnormalities in the visual system do appear to emerge at higher
levels and these may contribute towards visuoperceptive
dysfunction and visual hallucinations, which are common in
dementia with Lewy bodies. However, whether these abnormalities
include both the ventral and dorsal visual stream or are a product
of an interaction between the two remains to be resolved, and
certainly the integrity of lower visual areas may also be important
for maintaining certain aspects of visuoperceptual function. Our
understanding of the role of functional synaptic and neuro-
chemical changes in these lower areas also remains deficient. For
example, O’Brien et al37 found a relationship between nicotinic
receptor binding in primary and secondary visual cortices and
visual hallucinations in individuals with dementia with Lewy
bodies, which were not associated with occipital perfusion deficits,
suggesting that significant functional receptor changes can occur
in the absence of obvious alterations in perfusion. Further work
combining investigative modalities in individuals with dementia
with Lewy bodies that examine regional receptor changes,
perfusion/metabolism and functional responsivity to visual
stimuli and their relationship with observed clinical visual
symptomatology are needed.
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